Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-21 1:01 pm Sale |
2025-03-19 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 2,733,547 4.800% |
-5,784,292 (-67.91%) |
Filing History |
| 2025-02-14 2:36 pm Unchanged |
2024-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 8,517,839 15.100% |
0 (Unchanged) |
Filing History |
| 2024-11-14 1:28 pm Purchase |
2024-09-30 | 13G | Black Diamond Therapeutics, Inc. BDTX |
T. Rowe Price Investment Management, Inc. | 10,734,389 19.000% |
74,659 (+0.70%) |
Filing History |
| 2024-11-14 12:02 pm Purchase |
2024-09-30 | 13G | Black Diamond Therapeutics, Inc. BDTX |
Vestal Point Capital, LP | 5,028,500 8.900% |
5,028,500 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BLACKROCK INC BLK |
3,497,766 6.200% |
0 (Unchanged) |
Filing History |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BLACKROCK INC BLK |
3,497,766 6.200% |
2,225,654 (+174.96%) |
Filing History |
| 2024-08-08 4:48 pm Unchanged |
2024-08-06 | 13D | Black Diamond Therapeutics, Inc. BDTX |
Versant Venture Capital VI, L.P. | 4,328,883 7.700% |
0 (Unchanged) |
Filing History |
| 2024-07-10 2:17 pm Purchase |
2024-06-30 | 13G | Black Diamond Therapeutics, Inc. BDTX |
T. Rowe Price Investment Management, Inc. | 10,659,730 18.900% |
3,983,974 (+59.68%) |
Filing History |
| 2024-05-13 7:09 pm Purchase |
2024-05-09 | 13D | Black Diamond Therapeutics, Inc. BDTX |
New Enterprise Associates 16, L.P. | 4,546,947 8.100% |
1,098,190 (+31.84%) |
Filing History |
| 2024-05-09 8:48 pm Purchase |
2024-05-07 | 13D | Black Diamond Therapeutics, Inc. BDTX |
RA Capital Management, L.P. | 2,788,028 4.950% |
198,124 (+7.65%) |
Filing History |
| 2024-03-11 1:14 pm Purchase |
2024-02-29 | 13G | Black Diamond Therapeutics, Inc. BDTX |
T. Rowe Price Investment Management, Inc. | 6,675,756 12.900% |
2,747,877 (+69.96%) |
Filing History |
| 2024-02-14 10:04 am Purchase |
2023-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
T. Rowe Price Investment Management, Inc. | 3,927,879 7.600% |
3,927,879 (New Position) |
Filing History |
| 2024-02-13 06:05 am Purchase |
2023-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 8,517,839 16.500% |
3,140,000 (+58.39%) |
Filing History |
| 2023-11-09 5:24 pm Unchanged |
2023-08-11 | 13D | Black Diamond Therapeutics, Inc. BDTX |
Versant Venture Capital VI, L.P. | 4,328,883 8.400% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:14 pm Purchase |
2022-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 5,377,839 14.800% |
1,389,437 (+34.84%) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BLACKROCK INC BLK |
1,272,112 3.500% |
-976,355 (-43.42%) |
Filing History |
| 2022-04-14 12:01 pm Purchase |
2022-04-11 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 3,988,402 11.000% |
548,402 (+15.94%) |
Filing History |
| 2022-02-11 4:57 pm Purchase |
2021-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 3,440,000 9.500% |
1,540,000 (+81.05%) |
Filing History |
| 2022-02-09 3:33 pm Sale |
2021-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
The Vanguard Group | 1,014,791 2.800% |
-831,171 (-45.03%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BLACKROCK INC BLK |
2,248,467 6.200% |
2,248,467 (New Position) |
Filing History |